HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[HLA-associated predisposition to dilated cardiomyopathy].

Abstract
HLA-antigens grade I and II were studied by tissue typing in 60 Russians and 40 Georgians suffering from dilated cardiomyopathy (DCMP), and 40 Georgians with virus myocarditis. 267 test-donors Russians and 579 Georgians served as control. Markers of DCMP predisposition were found different for Russians and Georgians: DR4 (relative risk 2.96) and A11 (RR = 3.07), R12 (RR = 5.5), respectively. Georgians have a marker of resistance to DCMP--B35 (RR = 0.15). Antigen B12 marks a severe DCMP course in Georgians. Markers of virus myocarditis predisposition were distinct from those of DCMP: A1 (RR = 3.78) and B27 (RR = 3.62). This shows different etiology of the two diseases. The conclusion is made on nonidentical genetic markers of predisposition and resistance to the same disease in various populations.
AuthorsI S Polianskaia, L P Alekseev, V B Chumburidze, A P Iurenev, M G Guniia, P B Dubov, A G Dolbin
JournalKlinicheskaia meditsina (Klin Med (Mosk)) Vol. 68 Issue 6 Pg. 30-3 (Jun 1990) ISSN: 0023-2149 [Print] Russia (Federation)
Vernacular TitleAssotsirovannaia s HLA predraspolozhennost' k dilatatsionnoĭ kardiomiopatii.
PMID2145467 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • HLA Antigens
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-DR4 Antigen
Topics
  • Cardiomyopathy, Dilated (etiology, genetics, immunology)
  • Disease Susceptibility
  • Gene Frequency (genetics)
  • Georgia (Republic)
  • HLA Antigens (genetics)
  • HLA-A Antigens (genetics)
  • HLA-B Antigens (genetics)
  • HLA-DR4 Antigen (genetics)
  • Humans
  • Russia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: